Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma

被引:2
|
作者
Fang, Chen [1 ]
Dai, Jun [1 ]
Zhao, Juping [1 ]
Huang, Xin [1 ]
He, Wei [1 ]
Xu, Jianzhong [2 ,3 ]
Sun, Fukang [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai, Peoples R China
[3] 197 Ruijing 2nd Rd, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
adrenal vein sampling; adrenalectomy; computed tomography; hyperaldosteronism; surgical outcomes; ADRENALECTOMY; HYPERTENSION; MANAGEMENT; MUTATIONS; CONSENSUS; OUTCOMES;
D O I
10.1111/jch.14725
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Primary aldosteronism (PA) with unilateral adrenal disease can be cured or improved by adrenalectomy. Adrenal venous sampling (AVS) is recommended to identify patients for surgical management. However, surgeries based on computed tomography (CT) images are only advocated for PA patients aged <35 with visible unilateral adenoma. Herein, we aimed to compare CT-based and AVS-based surgery outcomes for PA patients with visible unilateral adenomas for different age groups. A total of 178 PA patients who underwent unilateral adrenalectomy between June 2018 and January 2021 were included in the study based on CT (n = 54) or AVS (n = 124). Demographics, diagnostics, and follow-up data were retrospectively collected. Clinical and biochemical outcomes were analyzed according to Primary Aldosteronism Surgical Outcome (PASO) criteria at 1-year follow-up. Our results showed that complete clinical success (46.3% vs. 47.6%, p = 0.875) and complete biochemical success (88.8% vs. 91.9%, p = 0.515) were similar between the two groups. Age stratification revealed that patients >55 years old were likely to have worse biochemical outcomes; however, these were still not significantly different (21.4% vs. 8.6%, p = 0.220). Of the 114 AVS-based patients who achieved complete biochemical success, 37 (32.4%) with bilateral normal or bilateral abnormal CT images changed treatment options according to AVS results, 1 (0.9%) avoided adrenalectomy on the wrong side. Our results indicated that surgery based on CT images might be feasible for highly selected PA patients with visible unilateral adenomas and less limited by age, while for those with normal adrenal or bilateral adrenal lesions, treatment strategy must be decided by AVS.
引用
收藏
页码:1001 / 1008
页数:8
相关论文
共 34 条
  • [31] Automatic diagnosis of stage of COVID-19 patients using an ensemble of transfer learning with convolutional neural networks based on computed tomography images
    Gifani, Parisa
    Vafaeezadeh, Majid
    Ghorbani, Mahdi
    Mehri-Kakavand, Ghazal
    Pursamimi, Mohamad
    Shalbaf, Ahmad
    Davanloo, Amirhossein Abbaskhani
    JOURNAL OF MEDICAL SIGNALS & SENSORS, 2023, 13 (02): : 101 - 109
  • [32] Temporal Changes in Subcutaneous Fibrosis in Patients with Lower Extremity Lymphedema Following Surgery for Gynecologic Cancer: A Computed Tomography-Based Quantitative Analysis
    Lee, Soyoung
    Lee, Dong Gyu
    Kim, Kyoung Tae
    DIAGNOSTICS, 2022, 12 (08)
  • [33] MRI-based vertebral bone quality score compared to quantitative computed tomography bone mineral density in patients undergoing cervical spinal surgery
    Oezel, Lisa
    Okano, Ichiro
    Jones, Conor
    Salzmann, Stephan N. N.
    Shue, Jennifer
    Adl Amini, Dominik
    Moser, Manuel
    Chiapparelli, Erika
    Sama, Andrew A. A.
    Carrino, John A. A.
    Cammisa, Frank P. P.
    Girardi, Federico P. P.
    Hughes, Alexander P. P.
    EUROPEAN SPINE JOURNAL, 2023, 32 (05) : 1636 - 1643
  • [34] Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study
    Gadducci, Angiolo
    Simonetti, Enrico
    Mezzapesa, Francesco
    Cosio, Stefania
    Miccoli, Mario
    Frey, Jessica
    Tintori, Rachele
    Bulleri, Alessandra
    Neri, Emanuele
    ANTICANCER RESEARCH, 2022, 42 (02) : 947 - 954